Latest Compliance News

Thrive Tribe Technologies (ASX:1TT) has locked in A$4 million through a share placement to accelerate its AI-enabled workforce engagement software, targeting enterprise and defence sectors.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Metal Bank has taken a significant step toward production at its Seven Leaders gold deposit by signing a non-binding MOU with Terra Mining for contract mining and crushing services, targeting a Q4 2026 start.

Silver Mines has bolstered its Bowdens Silver Project by acquiring a 3,345-hectare freehold land parcel for $12.5 million, enhancing water security, biodiversity efforts, and infrastructure options ahead of a key feasibility study.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Zimplats acknowledges Zimbabwe’s classification of platinum group metals as critical minerals and commits to working with the government to navigate the new policy framework while supporting local value addition.

Little Green Pharma has secured Federal Court approval for its full acquisition of Cannatrek, marking a key milestone in expanding its global medicinal cannabis footprint. The scheme became effective on 25 May 2026, with implementation set for 1 June.

Anax Metals has closed the second tranche of its placement, raising $4.8 million through a share issue that included $1.1 million from directors and granted options to its lead manager.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Omnia Metals has identified Beaver Creek within its Montana Radix Project as the key focus for rare earth and niobium exploration, leveraging historical data and planning detailed field validation.

Anteris Technologies Global Corp. has initiated an at-the-market equity offering to raise up to US$250 million, aiming to accelerate development of its DurAVR transcatheter heart valve and support general corporate needs.

Provaris Energy's proprietary liquified CO2 tank design has cleared a crucial Concept Selection milestone with Yinson, broadening its application beyond floating storage units to carriers and terminals, and advancing its path towards commercialisation.